Marinomed Biotech : publishes new supporting data on the in vitro efficacy of Carragelose® against SARS-CoV-2

By cineramaFebruary 18, 2021Altcoins

Marinomed Biotech AG (VSE:MARI), a globally operating biopharmaceutical company, announced today that further data on the efficacy of Carragelose® in preventing SARS-CoV-2 infection in vitro have been published in […]

Click here to view full article

Disclaimer

The statements, opinions and data contained on this site are solely those of the individual authors and contributors and not of the publisher of www.bitcoinisle.com. All content provided herein our website, hyperlinked sites, associated applications, forums, blogs, social media accounts and other platforms (“Site”) is for your general information only, procured primarily from third party sources. We make no warranties of any kind in relation to our content and services, including but not limited to accuracy, security and updatedness. No part of the content and services that we provide constitutes financial advice, legal advice or any other form of advice. Any use or reliance on our content and services is solely at your own risk and discretion. You should conduct your own research, review, analyze and verify our content and services before relying on or using them. Participating in cryptocurrency activities is a highly risky endeavor, please therefore consult your financial advisor before making any monetary decisions. No content on our Site is meant to be a solicitation or offer.

Marinomed Biotech : publishes new supporting data on the in vitro efficacy of Carragelose® against SARS-CoV-2

Tags:

Breaking News…

Previous PostVenus (XVS) rallies 900%, TVL hits $3.54B after Binance Smart Chain launch

Next PostBosch partners with Fetch.ai to ‘transform’ digital ecosystems using DLTs

Leave a Reply

Disclaimer